Events Details
Hepalink Pharma's US unit plans to invest in Quest PharmaTech, OncoQuest
Monday, October 12, 2015
Shenzhen Hepalink Pharmaceutical Co Ltd Says its U.S. unit, Hepalink USA Inc, plans to invest C$2 million in Quest PharmaTech Inc by subscribing 25 million new shares.
Says its U.S. unit, Hepalink USA Inc, plans to invest $13 million in OncoQuest Inc by subscribing preference shares.
Says plans to invest $5 million to set up JV in China with OncoQuest Inc.
reuters.com
